Skip to main content

Tetrahydrocannabihexol Facts

Cannabinoid; Cannabinoid; Cannabinoid CB1 receptor full agonist

Description

THCH (tetrahydrocannabihexol) — also known as parahexyl — is a cannabinoid of the dibenzopyran class. It is a direct homolog of Δ9-THC, its six-carbon side chain producing stronger cannabinoid receptor binding than conventional THC.[1][2] It activates these receptors more completely than THC, generating a more intense cannabis-type experience.

Subjective effects include sedation, euphoria, appetite enhancement, time alteration, and sensory intensification. The experience resembles cannabis but is steeper — the margin between comfortable and overwhelming narrows because THCH activates receptors more completely than THC can.

Dependence liability is presumed at least equivalent to cannabis; no lethal dose data exist for any species. As a full receptor activator — unlike THC, which is partial — THCH can push effects beyond what plant cannabis reaches, including prolonged unconsciousness documented in real cases.

Dose and duration

No dose or duration recorded for any route.

Body and dependence

Acute toxicity
Moderate
Chronic toxicity
Low
Physical dependence
Low
Psychological dependence
Moderate
Withdrawal
Moderate
Compulsive redosing
Low

Tolerance

Builds
Moderate
Fully resets after
21 days
Carries over to
Δ9-THC; Δ8-THC; THCP; THCB; HHC; Synthetic cannabinoids

Effectslikely at a common dose

Perception
none likely · 18 possible, including Spatial disorientation, Vestibular distortion, Visual haze / noise
Body
Body high; Dry mouth; +20 possible, including Abnormal heartbeat, Motor control impairment, Dizziness
Thinking
Cognitive impairment; Memory suppression; +32 possible, including Decision impairment, Information processing suppression, Analysis suppression
Feeling
none likely · 10 possible, including Anxiety, Emotional lability, Paranoia
Self
none likely · 14 possible, including Communication suppression, Depersonalization, Derealization
Time
Time alteration; +2 possible, including Temporal disorientation

Who shouldn't take it

Absolute
Psychotic disorders; Pregnancy and breastfeeding
Relative
Cardiovascular disease; Cannabis use disorder; Hepatic impairment; Adolescence; Concurrent CNS depressant use

Combinations60 recorded

Dangerous (27)
Benzodiazepines, Barbiturates; GHB, Baclofen; GHB, GBL; Opioids; Alpha-2 adrenergic receptor antagonist; Atypical antipsychotics; Benzodiazepines; Caffeine; Cannabis; Cannabis, THC; Clonidine, Guanfacine; Ephedrine, Pseudoephedrine; Gabapentin, Pregabalin; Ibogaine; Ketamine, DXM, PCP; Lithium; Local anesthetics; MAOIs; MDMA, MDA; NDRIs (Wellbutrin); Salvia, Ibogaine; SNRIs; SSRIs; THC; and 3 more, see full page
Caution (21)
See full page: psychedex.org/substances/tetrahydrocannabihexol
Not graded (12)
Not listed never means safe.

Seek help immediately if

Natural cannabis rarely causes a medical emergency — "greening out" is: pale/sweaty skin, dizziness, nausea or vomiting, anxiety or panic, rapid heartbeat, feeling faint — and usually passes with rest.

Seek emergency help for these — far more likely with synthetic cannabinoids ("spice" / K2):

  • Seizures
  • Severe chest pain; very fast or irregular heartbeat
  • Unresponsiveness or extreme drowsiness
  • Severe agitation, aggression, or psychosis
  • Repeated vomiting; difficulty breathing

What to do

  1. Sit or lie them down somewhere calm, cool, and quiet
  2. Reassure them — cannabis panic and "greening out" pass with time
  3. Offer sips of water; a little sugar can help if they feel faint
  4. Recovery position if nauseated, drowsy, or vomiting
  5. Stay with them and monitor
  6. For seizures, chest pain, unresponsiveness, or severe agitation, call emergency services

Natural cannabis "greening out" resolves with rest, calm, and time, with no lasting harm. Synthetic cannabinoids are unpredictable and can cause seizures, cardiac events, kidney injury, and severe agitation that needs emergency care.

988 Suicide & Crisis LifelineFireside Project: 62-FIRESIDE

Version r1 · Not medical advice

References

  1. [1]
    ^Janssens LK, Van Uytfanghe K, Williams JB, Hering KW, Iula DM, Stove CP (2024) Investigation of the intrinsic cannabinoid activity of hemp-derived and semisynthetic cannabinoids with β-arrestin2 recruitment assays - and how this matters for the harm potential of seized drugs — Archives of Toxicology doi:10.1007/s00204-024-03769-4
  2. [2]
    ^Bow EW, Rimoldi JM (2016) The Structure-Function Relationships of Classical Cannabinoids: CB1/CB2 Modulation — Perspectives in Medicinal Chemistry doi:10.4137/pmc.s32171
Print version
Report an issue